Maternal Medical Complications in Pregnancy Following Assisted Reproductive Technology
Pregnancies resulting from ART may have increased risks for maternal medical complications, especially gestational hypertension, pre-eclampsia, thromboembolism and gestational diabetes. These risks largely arise due to the characteristics of the women who undergo ART and are most marked in older women, those with high body mass index or polycystic ovary syndrome and in multiple pregnancies; but risks especially for pre-eclampsia are high when donor gametes have been used. Thorough risk assessment is important for each of these complications in early pregnancy, in order to plan surveillance or to institute prophylactic treatment. Women with significant underlying medical conditions need careful assessment prior to commencement of ART protocols to consider maternal and fetal risks in pregnancy, plan appropriate health surveillance during pregnancy and consider adjustment of medication.
KeywordsPre-eclampsia Gestational Hypertension Gestational Diabetes Venous thromboembolism Risk assessment Thromboprohylaxis Aspirin Blood pressure Surveillance
- 9.Office for National Statistics. Live births by characteristics of mother. England and Wales, 2010.Google Scholar
- 13.Toshimitsu M, Nagamatsu T, Nagasaka T, Iwasa-Kawai Y, Komatsu A, Yamashita T, et al. Increased risk of pregnancy-induced hypertension and operative delivery after conception induced by in vitro fertilization/intracytoplasmic sperm injection in women aged 40 years and older. Fertil Steril. 2014;102:1065–70.CrossRefPubMedGoogle Scholar
- 14.NICE guideline CG 107: Hypertension in pregnancy. 2011. https://www.nice.org.uk/guidance/cg107/evidence.
- 15.PRECOG: The pre-eclampsia community guideline. http://action-on-pre-eclampsia.org.uk/wp-content/uploads/2012/07/PRECOG-Community-Guideline.pdf.
- 16.NICE guideline NG 3: Diabetes in pregnancy. 2015. https://www.nice.org.uk/guidance/ng3/evidence.
- 17.RCOG. Thrombosis and embolism during pregnancy and the puerperium, reducing the risk (Green-top Guideline No. 37a). 2009. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg37areducingriskthrombosis.pdf.
- 24.Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Touraye H, Haentjens P. Levothyroxine treatment and pregnancy outcomes in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update. 2013;19:251–8.CrossRefPubMedGoogle Scholar
- 25.Chevalier N, Letur H, Lelannou D, Ohl J, Cornet D, Chalas-Boissonnas C, et al. Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome. J Clin Endocrinol Metab. 2011;96:E260–7.CrossRefPubMedGoogle Scholar
- 27.Scott-Pillai R, Spence D, Cardwell CR, Hunter A, Holmes VA. The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, 2004-2011. BJOG. 2013;120:932–9.Google Scholar
- 29.Centre for Maternal and Child Enquiries (CMACE). Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1–203.Google Scholar
- 38.NICE guideline CG 156: Fertility: assessment and treatment for people with fertility problems. 2013. https://www.nice.org.uk/guidance/cg156/evidence.